HLB Co., Ltd. HLB Co., Ltd.

HLB Co., Ltd.

028300

Clasificación en acciones #3919
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Precio por acción
$31.27
Capitalización bursátil
$4.16B
Cambio (1 día)
6.78%
Cambio (1 año)
1.26%
País
KR
Comercio HLB Co., Ltd. (028300)

Categoría

Healthcare
Historial del precio de la acción de HLB Co., Ltd. (028300)
Precio más alto de cierre: $29.89 el 2026-10-01

Precio más bajo de cierre: $1.36 el 2008-12-01
Historial del precio de la acción de HLB Co., Ltd. desde 2008 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.63%
2025 -33.96%
2024 57.41%
2023 40.26%
2022 -17.38%
2021 -30.97%
2020 8.36%
2019 23.72%
2018 110.61%
2017 199.59%
2016 -34.89%
2015 161.99%
2014 189.01%
2013 -5.55%
2012 30.30%
2011 0.39%
2010 -50.22%
2009 13.14%
2008 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$536.13 25.72%
US
$200.12 645.31%
US
$137.83 -3.78%
AU
$291.76 2.51%
BE
$880.01 8.09%
NL